VI001 - DTP primary course completed before 8 months of age
The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF).
Indicator definition
Indicator ID | Description |
VI001 | The percentage of babies who reached 8 months old in the preceding 12 months, who have received at least 3 doses of a diphtheria, tetanus and pertussis containing vaccine before the age of 8 months. |
What do the business rules mean?
What makes a patient eligible?
Patients are eligible for the VI001 denominator if they turned 8 months old during the service year, (ie: on the 31st March of the QOF year, the patient was at least 8 months old but not yet 20 months old).
How to achieve the indicator
To meet the criteria for VI001, eligible patients must have received three separate doses of hexavalent diphtheria, tetanus and pertussis containing vaccine administered before they reached 8 months of age (248 days old).
What will remove patients from eligibility?
- they have a contraindication to a diphtheria, tetanus and pertussis containing vaccine recorded before they reached 8 months of age
they were registered on or after the date they reached 8 months of age (248 days old)
they were registered on or after the date they reached 7 months of age (217 days old) and had received only two, or fewer, doses of a diphtheria, tetanus and pertussis containing vaccine prior to registering
they were registered on or after the date they reached 6 months of age (186 days old) and had received only one dose, or no doses, of a diphtheria, tetanus and pertussis containing vaccine prior to registering
they were registered on or after the date they reached 5 months of age (155 days old) and had received no doses of a diphtheria, tetanus and pertussis containing vaccine prior to registering
There are no Personalised Care Adjustments to remove a patient if vaccination has been declined. This is likely to make the indicator hard to achieve, either due to a small number of dissenting patients or due to transient populations where new patients completed a different vaccination schedule abroad.
If a patient achieves the
indicator at any point during the year, any exclusions that have also been
added are ignored.
Hints and tips for achieving this indicator
The PCIT searches can help you to identify patients that you need to action to achieve this indicator.
SNOMED codes used in this indicator
The codes referenced in this article are taken from the NHS Technology Reference Update Distribution (TRUD). Not all of these may be present or selectable in all clinical systems.
Codes for Diphtheria, tetanus and pertussis containing vaccine contraindication codes (DTPCON_COD)
SNOMED code | SNOMED code description |
1083421000000107 | Diphtheria, tetanus and acellular pertussis, inactivated polio, Haemophilus influenzae type b and hepatitis B vaccination contraindicated |
171284002 | Pertussis vaccine contraindicated |
219084006 | Adverse reaction to component of vaccine product containing Clostridium tetani antigen |
219085007 | Adverse reaction to component of vaccine product containing Corynebacterium diphtheriae antigen |
293108006 | Adverse reaction to component of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens |
293109003 | Adverse reaction to component of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens |
293115003 | Adverse reaction to component of vaccine product containing Bordetella pertussis antigen |
294642009 | Allergy to component of vaccine product containing Corynebacterium diphtheriae antigen |
294644005 | Allergy to component of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens |
294645006 | Allergy to component of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens |
294651001 | Allergy to component of vaccine product containing Bordetella pertussis antigen |
294658007 | Allergy to component of vaccine product containing Clostridium tetani antigen |
715163003 | Diphtheria vaccination contraindicated |
719474005 | Tetanus vaccination contraindicated |
897351000000102 | Diphtheria, tetanus, acellular pertussis, inactivated polio vaccination contraindicated |
898291000000101 | Diphtheria, tetanus, acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b vaccination contraindicated |
903241000000108 | Diphtheria, tetanus, inactivated polio vaccination contraindicated |
Related Articles
IIF VI-01 / VI-02 / VI-03
VI-01 (NCD002) Percentage of patients aged 65 years or over, who received a seasonal influenza vaccination between 1 September and 31 March This indicator is looking at patients born before 1st April 1958. There are some exclusions for patients with ...VI002 - 1st MMR given before 18 months of age
The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). Indicator definition Indicator ID Description VI002 The percentage of children who reached 18 months old in the preceding ...VI003 - Pre school boosters given before 5 years of age
The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). Indicator definition Indicator ID Description VI003 The percentage of children who reached 5 years old in the preceding ...MH021 - Completed Physical Health Check for SMI
The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). This indicator is protected in the contract year 2024/25 and will be paid at 2023/24 performance levels Indicator ...HYP009 - Hypertensive, age 80+, BP 150/90 mmHg or less
The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). Indicator definition Indicator ID Description HYP009 The percentage of patients aged 80 years or over, with hypertension, ...